CTKB

MKT CAP:$532M

Cytek Biosciences Inc

Market Cap

$532M

Healthcare·Medical Devices·🇺🇸 United States·NASDAQ

Healthcare·Medical Devices·🇺🇸·NASDAQ

Stock Price

$4.09-$0.83 (-16.87%)

Jun 5, 2026

52W High $5.8852W Low $2.95

Company Details

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cyt...

CEO

—

IPO Date

Jul 23, 2021

Website

cytekbio.com

Key Metrics TTM

Revenue

$204M

+3.6% YoY

Net Income

-$74M

EPS (Diluted)

Free Cash Flow

-$13M

Revenue / Share

$1.59

Gross Margin

51.7%

Operating Margin

-21.5%

Net Margin

-36.2%

FCF Margin

-6.2%

P/S

2.6x

P/E

Earnings Reports

Q2 2026

Aug 6, 2026

PENDING

Q1 2026

May 7, 2026

$44M+6.5%

FY 2025

Feb 26, 2026

$201M+0.5%

Q4 2025

Feb 26, 2026

$62M+8.1%

Q3 2025

Nov 5, 2025

$52M+1.5%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee